FILE – In this March 2021 photo provided by Pfizer, a technician works on a line for packaging preparation for the Pfizer-BioNTech COVID-19 vaccine at the company’s facility in Puurs, Belgium. Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus. (AP)
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
COVID-19 vaccine boosters could mean billions for drugmakers
Previous ArticleFormer WTMX staffer sues ‘Eric in the Morning’ host Eric Ferguson, alleging radio star coerced sexual favors
Next Article Why coffee could cost more at groceries, cafes